Québec – The Government of Canada is investing in a robust, dynamic and resilient life sciences ecosystem capable of responding to current and future health emergencies. Since March 2020, over $2.2 billion has been invested to strengthen domestic biomanufacturing capabilities and help keep Canadians healthy and safe. Jean-Yves Duclos, Minister of Public Services and Procurement and Quebec Lieutenant, on behalf of …
Ottawa – Your child will need to be vaccinated at different times in their life to get the best protection against vaccine-preventable diseases. Vaccination schedules are designed to provide protection before children are likely to be exposed to the disease. Vaccination schedules may be different depending on the province or territory you live in. No matter where you live in Canada, …
Main – Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced that the U.S. Food and Drug Administration (“FDA”) has approved the supplemental Biologics License Application for individuals 12 years of age and older (COMIRNATY® (COVID-19 Vaccine, mRNA)), and granted emergency use authorization for individuals 6 months through 11 years of age (Pfizer-BioNTech COVID-19 Vaccine) of the companies’ Omicron KP.2-adapted …
Washington – the CDC recommended the updated 2024-2025 COVID-19 vaccines and the updated 2024-2025 flu vaccines to protect against severe COVID-19 and flu this fall and winter. It is safe to receive COVID-19 and flu vaccines at the same visit. Data continue to show the importance of vaccination to protect against severe outcomes of COVID-19 and flu, including hospitalization and …
London – According to The Telegraph, amid “rare and dangerous side effect” of its COVID-19 vaccine, UK-based pharmaceutical manufacturer AstraZeneca has announced withdrawal of its inoculation jab. It will also be withdraw Vaxzevria’s marketing authorisations within Europe. The firm’s application to withdraw the vaccine was made on March 5 and came into effect on May 7.
KIRKLAND, QUEBEC and MAINZ, GERMANY – Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that COMIRNATY, the Pfizer-BioNTech COVID-19 Vaccine, has been named the 2023 winner of the Prix Galien Canada Innovative Product Award. COMIRNATY is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in …
Ottawa – Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for individuals six months of age and older. Health Canada received Pfizer-BioNTech’s submission on June 29, 2023. After a thorough and independent review of the evidence, Health Canada has determined that the vaccine meets the Department’s stringent safety, efficacy and quality requirements. …
Current recommendations An updated Covid-19 vaccine has been approved by Health Canada and will be available for use. Covid-19 vaccination reduces the risk of severe illness, death and post Covid-19 condition (long Covid). Starting in fall 2023, it’s recommended that you get an updated Covid-19 vaccine dose if it’s been at least 6 months: since your last Covid-19 vaccine dose …
TORONTO — Ontario is reminding everyone to stay safe this respiratory illness season and prevent unnecessary visits to the hospital by staying up to date on vaccinations. Ontarians are encouraged to get their flu and COVID-19 shots as soon as they are available to them. “Our government is making sure Ontarians can connect to tools they need to keep themselves …
Ottawa – Health Canada has authorized the use of the Moderna SPIKEVAX™ Covid-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older. Health Canada received Moderna’s submission for its new Covid-19 vaccine on June 29, 2023. After a thorough, independent review of the evidence, Health Canada has determined that the vaccine meets the Department’s stringent safety, …
